{
  "id": 9232597,
  "title": "China’s cancer breakthrough on CAR-T cell therapy shows progress",
  "url": "https://urgent.news/2026/09/23/chinas-cancer-breakthrough-on-car-t-cell-therapy-shows-progress-9232597",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-23T00:45:04.000Z",
  "source": {
    "name": "Reuters Business via SCMP",
    "slug": "reuters-business-via-scmp",
    "url": "https://www.scmp.com/plus/news/china/science/article/3368352/chinas-cancer-breakthrough-car-t-cell-therapy-shows-progress"
  },
  "original_language": "en",
  "account": null,
  "summary": "In June, Chinese regulators approved the world’s first CAR-T cell therapy for solid tumour cancers, developed by a drug company based in Shanghai. One month later, at a hospital in the city, a New Zealander with advanced cancer of the stomach and small intestine became the first international patient to receive the breakthrough treatment. Chimeric antigen receptor T-cell therapy, to give it its…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "South China Morning Post",
        "title": "China’s cancer breakthrough on CAR-T cell therapy shows progress",
        "url": "https://urgent.news/2026/09/23/chinas-cancer-breakthrough-on-car-t-cell-therapy-shows-progress",
        "published": "2026-09-23T00:45:04.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}